Compass Therapeutics, Inc. announced the appointment of two new directors to its board. Joining the board of directors are Ellen Chiniara, JD, former Chief Legal Officer of Alexion Pharmaceuticals, and Mary Ann Gray, PhD, President of Gray Strategic Advisors. Ms. Chiniara and Dr. Gray are both global leaders with deep experience in the life sciences and biopharmaceutical industries.

Ms. Chiniara was most recently Executive Vice President, Chief Legal Officer and Corporate Secretary of Alexion Pharmaceuticals until its acquisition by AstraZeneca in July 2021. Dr. Gray is the President of Gray Strategic Advisors, LLC. She currently serves on the boards of five public biotechnology companies: BioAtla, Keros Pharmaceuticals, Palisade Bio, Rapt Therapeutics, and Sarepta Pharmaceuticals.

Ms. Chiniara was also appointed to serve as a member of the Company's Nominating and Corporate Governance Committee and its Compensation Committee.